23andMe Appoints Three New Independent Directors to Board

Stock Information for Cardlytics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cardlytics Inc.

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador's Precision Medicines for Immunology & Inflammation
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
23andMe to Report Q2 FY2025 Financial Results
23andMe Regains Compliance With Nasdaq Listing Requirements
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South
23andMe Announces Completion of 1-for-20 Reverse Stock Split

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.